Authors' reply to: "The long-term recurrence rate of minimally invasive methods in pilonidal sinus disease therapy is still unclear"

Tech Coloproctol. 2022 Feb;26(2):159-160. doi: 10.1007/s10151-021-02559-9. Epub 2022 Jan 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Neoplasm Recurrence, Local
  • Pilonidal Sinus* / surgery
  • Prospective Studies
  • Skin Diseases*
  • Treatment Outcome